Glenmark Life Sciences Share Price
(ALIVUS)
Check the latest share price of Glenmark Life Sciences, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 09 May 2025
NSE
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 15.57 % |
3 Month Return | -7.33 % |
1 Year Return | + 34.77 % |
3 Year Return | + 154.67 % |
5 Year Return | + 49.04 % |
Market Stats | |
Previous Close | ₹1,106.10 |
Open | ₹1,075.30 |
Volume | 60.38K |
Upper Circuit | ₹1,327.30 |
Lower Circuit | ₹884.90 |
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹13,680.51 Cr
Return on Equity (ROE)
21.07
PE Ratio (TTM)
0Return on capital employed (ROCE)
27.94
Beta (LTM)
0.62
P/B Ratio
4.07
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
15.32
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Investing in Glenmark Life Sciences is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Glenmark Life Sciences or ALIVUS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Glenmark Life Sciences or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Glenmark Life Sciences with just a few clicks!
Get updated buy, sell, and hold recommendations by analysts on Glenmark Life Sciences.
based on 4 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
80% of analysts recommend a 'BUY' rating for Glenmark Life Sciences. Average target price of ₹1296.25
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Glenmark Life Sciences.
Glenmark Life Sciences price forecast by 4 analysts
Upside of16.19%
High
₹1360
Target
₹1296.25
Low
₹1150
Glenmark Life Sciences target price ₹1296.25, a slight upside of 16.19% compared to current price of ₹1115.6. According to 4 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Glenmark Life Sciences revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Glenmark Life Sciences EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Get the annual and quarterly financial summary of Glenmark Life Sciences, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Glenmark Life Sciences.
Alivus Life Sciences Ltd’s net profit jumped 15.32% since last year same period to ₹136.96Cr in the Q3 2024-2025. On a quarterly growth basis, Alivus Life Sciences Ltd has generated 43.68% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2023, Alivus Life Sciences Ltd has declared dividend of ₹22.50 - translating a dividend yield of 3.90%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Glenmark Life Sciences.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 74.99% | 0.00 | |
Foreign Institutions | 6.57% | 0.00 | |
Mutual Funds | 3.59% | 0.00 | |
Retail Investors | 13.25% | 0.00 | |
Others | 1.59% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Glenmark Life Sciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
BUY | 13,680.51 | 9.81% | 0.51 | 470 | 2,283 | |
NA | 58.57 | -3.99% | 0.57 | 3 | 46 | |
NA | 2,053.56 | 28.26% | 0.51 | 58 | 630 | |
NA | 119.90 | -15.78% | 0.50 | 1 | 2 | |
NA | 135.71 | 39.27% | 0.51 | 11 | 167 |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, ALIVUS has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Price Rise
In the last 7 days, ALIVUS stock has moved up by 2.6%
MF Holding Up
Mutual Funds have increased holdings from 3.23% to 3.59% in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.8% return, outperforming this stock by 24.1%
Retail Holding Down
Retail Investor have decreased holdings from 13.40% to 13.25% in Mar 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 6.74% to 6.57% in Mar 2025 quarter
Promoter Holding Down
Promoters have decreased holdings from 75.00% to 74.99% in Mar 2025 quarter
Organisation | Alivus Life Sciences Ltd |
Industry | Pharmaceuticals |
CEO | Glenn Saldanha |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Glenmark Life Sciences.
Alivus Life Sciences Ltd share price today stands at ₹1115.6, Open: ₹1075.3, Previous Close: ₹1106.1, High: ₹1124.8, Low: ₹1069.1, 52 Week High: ₹1335.1, 52 Week Low: ₹755.95.
Today's traded volume of Alivus Life Sciences Ltd(ALIVUS) is 60.38K.
Today's market capitalisation of Alivus Life Sciences Ltd(ALIVUS) is ₹13,680.51 Cr.
Alivus Life Sciences Ltd (ALIVUS) share price is ₹1115.6. It is down -16.44% from its 52 Week High price of ₹1335.1
Alivus Life Sciences Ltd (ALIVUS) share price is ₹1115.6. It is up 47.58% from its 52 Week Low price of ₹755.95